Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donagh Egan

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Iscience|July 18, 2024
BTLA and PD-1 signals attenuate TCR-mediated transcriptomic changesMuhammad Zainul Arifin, Judith Leitner, Donagh Egan, et al.
Iscience|January 29, 2025
Erratum: BTLA and PD-1 signals attenuate TCR-mediated transcriptomic changesMuhammad Zainul Arifin, Judith Leitner, Donagh Egan, et al.
Frontiers in Oncology|November 10, 2025
Oxphos targeting of <i>MYCN</i>-amplified neuroblastomaSoraya Epp, Donagh Egan, Evon Poon, et al.
NPJ Precision Oncology|June 16, 2025
A temporal model of tumor-immune dynamics during the metastatic progression of high-grade serous ovarian cancerDonagh Egan, Kate Glennon, Ann Treacy, et al.
Gynecologic Oncology|September 26, 2022
CRABP2 - A novel biomarker for high-risk endometrial cancerDonagh Egan, Bruce Moran, Michael Wilkinson, et al.
British Journal of Pharmacology|June 18, 2025
Assessment of the molecular mechanisms of drug-induced hidden cardiotoxicity by a multi-omics approach: The example of rofecoxibBennet Y Weber, Gábor B Brenner, Barnabás Váradi, et al.
Cancer Immunology Research|May 25, 2023
Small Gene Networks Delineate Immune Cell States and Characterize Immunotherapy Response in MelanomaDonagh Egan, Martina Kreileder, Myriam Nabhan, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Iscience|July 18, 2024
BTLA and PD-1 signals attenuate TCR-mediated transcriptomic changesMuhammad Zainul Arifin, Judith Leitner, Donagh Egan, et al.
Iscience|January 29, 2025
Erratum: BTLA and PD-1 signals attenuate TCR-mediated transcriptomic changesMuhammad Zainul Arifin, Judith Leitner, Donagh Egan, et al.
Frontiers in Oncology|November 10, 2025
Oxphos targeting of <i>MYCN</i>-amplified neuroblastomaSoraya Epp, Donagh Egan, Evon Poon, et al.
NPJ Precision Oncology|June 16, 2025
A temporal model of tumor-immune dynamics during the metastatic progression of high-grade serous ovarian cancerDonagh Egan, Kate Glennon, Ann Treacy, et al.
Gynecologic Oncology|September 26, 2022
CRABP2 - A novel biomarker for high-risk endometrial cancerDonagh Egan, Bruce Moran, Michael Wilkinson, et al.
British Journal of Pharmacology|June 18, 2025
Assessment of the molecular mechanisms of drug-induced hidden cardiotoxicity by a multi-omics approach: The example of rofecoxibBennet Y Weber, Gábor B Brenner, Barnabás Váradi, et al.
Cancer Immunology Research|May 25, 2023
Small Gene Networks Delineate Immune Cell States and Characterize Immunotherapy Response in MelanomaDonagh Egan, Martina Kreileder, Myriam Nabhan, et al.
Pageof 1